This was the stock's second consecutive day of gains.

Humana faces significant earnings headwinds due to CMS reforms, star rating downgrades, and potential Medicaid clawbacks.

A return of a former CEO and questions about its Medicare Advantage pricing dominate the outlook for this formerly ...

The tech-heavy Nasdaq Composite rallied more than 9% this month. Information technology stocks are the top-performing sector ...

Humana (NYSE:HUM) recently reported first-quarter earnings, showcasing a revenue increase from USD 29,611 million to USD 32,112 million and a net income rise from USD 741 million to USD 1,244 million.

U.S. equities were little changed at midday with the market focused on comments from the Federal Reserve coming later today.

Revenue Growth: Over the 3M period, Humana showcased positive performance, achieving a revenue ... Analysts typically rate each stock once per quarter. Some analysts will also offer forecasts ...

Despite these developments, Humana's stock performance remained flat over the past week. During the same period, broader markets saw gains, bolstered by strong earnings from major tech companies.

In premarket trading, Humana’s stock rose 6.03%, reflecting investor confidence in the company’s robust performance and strategic outlook. According to InvestingPro analysis, Humana currently appears ...

In premarket trading, Humana’s stock rose 6.03%, reflecting investor confidence in the company’s robust performance and strategic outlook. According to InvestingPro analysis, Humana currently ...

The company's recent financial performance has been mixed. While Humana has maintained a solid ... HUM appears on our undervalued or overvalued stock lists. These tools provide a clearer picture ...